Emblem Corp. (TSXV:EMC, OTCQX: EMMBF) (“Emblem” or the “Company”) announces that the Ontario Superior Court of Justice (Commercial List) granted the Company’s motion for an interim order authorizing various matters, including the mailing of a management information circular (the “Circular”) and the holding of the special meeting of Emblem shareholders to be held on Wednesday March 6, 2019 at 10:30 a.m. (Toronto time) at the offices of Dentons Canada LLP, 77 King Street West, Suite 400, Toronto, Ontario, M5K 0A1 (the “Meeting”).

The Meeting will be held to consider the previously announced proposed arrangement (the “Arrangement”) involving Emblem and Aleafia Health Inc. (“Aleafia”) described in the joint press release issued by Emblem and Aleafia on December 19, 2018 (the “Arrangement”), as well as certain other Meeting matters as set out in the Circular mailed to shareholders.

The board of directors of Emblem has unanimously recommended that shareholders vote FOR the Arrangement. Each of the directors and Chief Executive Officer and Chief Financial Officer of the Company, together with certain shareholders, holding in aggregate approximately 12% of the Company’s issued and outstanding common shares, have entered into support and voting agreements pursuant to which they have agreed to, among other things, vote their common shares FOR the Arrangement.

Shareholders of record on January 30, 2019 will receive notice of and be entitled to vote at the Meeting. Full details of the Arrangement, and all other matters to be considered by shareholders at the Meeting, are contained in the Circular mailed to shareholders and available under the Company’s SEDAR profile at www.sedar.com. All shareholders are urged to carefully read the Circular, and all other materials delivered and filed in connection with the Meeting.

On December 16, 2018, the board of directors of the Company adopted amended by-laws which now provide for a 10% quorum requirement for shareholder meetings and certain other changes pertaining to corporate signing authority, roles of certain officers and the location of the Company’s registered address. Shareholders will also be asked to confirm and approve the amended by-laws at the Meeting.

Any shareholders who have questions about the Arrangement or other matters to be considered at the Meeting should contact Emblem’s strategic shareholder advisor and information agent Kingsdale Advisors, toll free at 1-866-581-0508 (toll free in North America), or at 416-867-2272 (collect outside of North America), or by email at contactus@kingsdaleadvisors.com. Any shareholders who need assistance with the completion and delivery of their proxy or letter of transmittal, please contact Emblem’s depositary, Computershare Investor Services Inc. (toll free in North America) at 1-800-564-6253 or by email at corporateactions@computershare.com.

In addition, the Company has entered into an investor relations services agreement (the “Services Agreement”) with LodeRock Advisors Inc. (“LodeRock”) pursuant to which LodeRock will provide Emblem with strategic investor relations and capital markets communications services. LodeRock is a group of senior capital markets communications executives who develop and execute communications programs in order to help companies achieve their capital markets objectives.

The Services Agreement is for a term of approximately two (2) months, commencing February 4, 2019 and concluding March 31, 2019. Pursuant to the terms of the Services Agreement, Emblem will pay LodeRock a retainer fee of $30,000, payable in instalments of $10,000 upon execution and on each of February 28, 2019 and March 31, 2019. Emblem has no prior professional relationship with LodeRock and as of the date of this release, LodeRock does not own or control any securities of the Company. The Company is also announcing that its previously announced advisory agreement with e.vestor Communications Inc. was terminated as of December 31, 2018.

About Emblem

Emblem is a fully integrated cannabis company focused on driving shareholder value through product innovation, brand relevance, and access to patient and consumer channels. Through its wholly-owned subsidiary Emblem Cannabis Corporation, Emblem is licensed to cultivate, process, and sell cannabis and cannabis derivatives in Canada under the Cannabis Act. Emblem’s state-of-the-art indoor cannabis cultivation facility and Product Innovation Centre is located in Paris, Ontario. Emblem is also the parent company of GrowWise Health Limited, one of Canada’s leading cannabis education services. Emblem trades under the ticker symbol EMC on the TSX Venture Exchange.

For more information, please visit www.emblemcorp.com.

For media inquiries, please contact:

Deborah Rowe
H+K Strategies

For further information contact:

Kingsdale Advisors
Toll-Free (within North America): 1.866.581.0508
Call Collect (outside North America): 416.867.2272

Alex Stojanovic
Chief Financial Officer
Emblem Corp.


Certain information in this news release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward looking statements. Forward-looking statements in this news release include, but are not limited to, statements and information concerning the anticipated Meeting and the expected timing thereof and related matters, the engagement of LodeRock and the retainer fee payable to LodeRock. Readers are cautioned that the foregoing list is not exhaustive, and that, in particular, there can be no assurance that the Company will receive the requisite approvals for the proposed Arrangement (if at all) including court, regulatory, stock exchange and shareholder approval, or that the Arrangement will be completed even if all necessary approvals are obtained at the Meeting. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement and reflect our expectations as of the date hereof, and thus are subject to change thereafter. Emblem disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

There can be no assurance that the Arrangement will occur, or that it will occur on the terms and conditions contemplated in this news release. The Arrangement could be modified, restructured or terminated. Actual results could differ materially from those currently anticipated due to a number of factors and risks.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

Click here to connect with Emblem (TSXV:EMC,OTCQX:EMMBF) for an Investor Presentation.

Source: globenewswire.com

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws.

To join the Aurora class action, go to http://www.rosenlegal.com/cases-register-1965.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

Keep reading... Show less

Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Aurora Cannabis Inc. (NYSE: ACB) from February 13, 2020 through September 4, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Aurora Cannabis Inc. investors under the federal securities laws.

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email info@pawarlawgroup.com for information on the class action.

Keep reading... Show less

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less